Evidence map›Paper›PMID 24470011›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Cutis verticis gyrata in association with vemurafenib and whole-brain radiotherapy.

James J Harding, Christopher A Barker, Richard D Carvajal, Jedd D Wolchok, Paul B Chapman, Mario E Lacouture

Abstract readCase Reports
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Acne Keloidalis Nuchae is Associated with Cutis Verticis Gyrata.Clinical, cosmetic and investigational dermatology · 2022
    Article
  4. Article
  5. Article
  6. Primary EssentialSultan Qaboos University medical journal · 2018
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. [Developmental abnormalities and nevi of the scalp].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2014
    Article
  13. Article
  14. [Cutaneous side effects of anti-tumor therapy with BRAF and MEK inhibitors].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2014
    Article
  15. Article
  16. A case of cutis verticis gyrata related to pregnancy.Indian journal of dermatology, venereology and leprology
    Article
  17. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

James J HardingMemorial Sloan-Kettering Cancer Center, New York, NY.
Christopher A Barker
Richard D Carvajal
Jedd D Wolchok
Paul B Chapman
Mario E Lacouture

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Investigational Cancer Therapeutics Training Program (ICTTP)T32CA009207 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Omar Abdel-Wahab, Alexander Drilon · 1985 to 2026
$13.7M
Summer research experiences for medical students supervised by faculty mentorsR25CA020449 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Charlotte Eielson Ariyan · 1985 to 2026
$6.2M
NCI NIH HHS P30 CA008748NCI NIH HHS R25 CA020449NCI NIH HHS T32 CA009207
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAntineoplastic AgentsCranial IrradiationFemaleHumansIndolesMaleMelanomaMiddle AgedNeoplasm MetastasisScalp DermatosesSkin NeoplasmsSulfonamidesVemurafenibAntineoplastic AgentsIndolesSulfonamidesVemurafenib

Identifiers

PMID24470011
PMCPMC4879708

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.